People · Operator
Named in public records as an officer, director or promoter · active 2014–2015 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Bionpharma Inc. | — | Pharmaceuticals | Series B | $88.4M | $221.0M | 2014 |
Richard W. Van Duyne at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Richard W. Van Duyne on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| James Gale | 1 | 5 |
| Venkatachalam Krishnan | 1 | 1 |
| Carol S. Ben-Maimon | 1 | 1 |
| David W. Goodman | 1 | 1 |
| Lavesh W. Samtani | 1 | 1 |
| Gaurav W. Mehrotra | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.